Edwards Lifesciences' Q4 Update: Results Were Mixed, but Guidance Was Great
Edwards Lifesciences (NYSE: EW) delivered stellar third-quarter earnings results in October. Those results helped power the stock to a whopping 52% gain last year.
But Edwards' momentum stalled somewhat during January. That could change, though, after the company reported its fiscal 2019 fourth-quarter and full-year results after the market closed on Thursday. Here are the highlights from Edwards' Q4 update.
Image source: Edwards Lifesciences.
Source Fool.com
